Trials / Not Yet Recruiting
Not Yet RecruitingNCT06905314
A Single Ascending Dose of HRS-4029 in Healthy Subjects
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HRS-4029 Following a Single Dose in Healthy Subjects
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 55 (estimated)
- Sponsor
- Beijing Suncadia Pharmaceuticals Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The study is being conducted to evaluate the safety, tolerability and pharmacokinetics of HRS-4029 following a single intravenous dose administration in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-4029 | HRS-4029 |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2025-04-01
- Primary completion
- 2025-10-01
- Completion
- 2025-12-01
- First posted
- 2025-04-01
- Last updated
- 2025-04-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06905314. Inclusion in this directory is not an endorsement.